Risks and benefits of antiarrhythmic therapy.

Suppr

超能文献

作者信息

Roden D M

机构信息

Division of Clinical Pharmacology, Vanderbilt University, Nashville, TN 37232-6602.

出版信息

N Engl J Med. 1994 Sep 22;331(12):785-91. doi: 10.1056/NEJM199409223311207.

DOI:10.1056/NEJM199409223311207

PMID:8065408

Abstract

摘要

相似文献

Risks and benefits of antiarrhythmic therapy.

N Engl J Med. 1994 Sep 22;331(12):785-91. doi: 10.1056/NEJM199409223311207.

[The pro-arrhythmic effects of anti-arrhythmia agents].[抗心律失常药物的促心律失常作用]

Z Kardiol. 1994;83 Suppl 5:75-85.

Drugs, QT interval abnormalities and ventricular arrhythmias.药物、QT间期异常与室性心律失常。

Adverse Drug React Toxicol Rev. 1994 Summer;13(2):77-102.

Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.在一名曾在β受体阻滞剂治疗期间发生过尖端扭转型室速的患者中，胺碘酮诱发尖端扭转型室速。

Can J Cardiol. 1997 Apr;13(4):383-6.

A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.七种抗心律失常药物治疗室性快速性心律失常患者的比较。电生理研究与心电图监测研究者。

N Engl J Med. 1993 Aug 12;329(7):452-8. doi: 10.1056/NEJM199308123290702.

What have clinical trials taught us about proarrhythmia?关于致心律失常作用，临床试验告诉了我们什么？

Can J Cardiol. 1996 Apr;12 Suppl B:20B-26B.

Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.使用III类抗心律失常药物进行单药治疗与联合治疗以减轻复极跨壁离散度：尖端扭转型室速的一个潜在危险因素

Pharmacotherapy. 2007 Sep;27(9):1297-305. doi: 10.1592/phco.27.9.1297.

[Clinical evaluation of new anti-arrhythmia drugs after the CAST (Cardiac Arrhythmia Suppression Trial) study].

Z Kardiol. 1992;81 Suppl 4:145-9.

QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.口服红霉素碱与奎尼丁同时给药时QT间期延长及尖端扭转型室速的发生

Pharmacotherapy. 1997 May-Jun;17(3):626-30.

Is there a need for new antiarrhythmic drugs?是否需要新型抗心律失常药物？

Arch Mal Coeur Vaiss. 1996 Feb;89 Spec No 1:13-8.

引用本文的文献

In Vitro Models for Improved Therapeutic Interventions in Atrial Fibrillation.用于改善心房颤动治疗干预的体外模型

J Pers Med. 2023 Aug 8;13(8):1237. doi: 10.3390/jpm13081237.

Postoperative New-Onset Atrial Fibrillation following Noncardiac Operations: Prevalence, Complication, and Long-Term MACE.非心脏手术后新发房颤：患病率、并发症及长期主要不良心血管事件

Cardiol Res Pract. 2020 Oct 14;2020:8156786. doi: 10.1155/2020/8156786. eCollection 2020.

Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials.心力衰竭伴射血分数降低的心房颤动导管消融治疗：随机对照试验的系统评价和荟萃分析。

BMC Cardiovasc Disord. 2019 Jan 15;19(1):18. doi: 10.1186/s12872-019-0998-2.

Profile of patients presenting with sustained ventricular tachycardia in a tertiary care center.三级医疗中心持续性室性心动过速患者的概况。

Indian Heart J. 2018 Sep-Oct;70(5):699-703. doi: 10.1016/j.ihj.2017.10.015. Epub 2017 Oct 28.

Electrophysiological Changes of the Atrium in Patients with Lone Paroxysmal Atrial Fibrillation.孤立性阵发性心房颤动患者心房的电生理变化

J Atr Fibrillation. 2010 Aug 23;3(2):251. doi: 10.4022/jafib.251. eCollection 2010 Aug-Sep.

Amiodaron in atrial fibrillation: post coronary artery bypass graft.胺碘酮用于冠状动脉旁路移植术后房颤治疗

World J Emerg Med. 2016;7(4):250-254. doi: 10.5847/wjem.j.1920-8642.2016.04.002.

Comparison of the Length of Hospital Stay between the Patients with Atrial Fibrillation Treated with Amiodarone and Patients with Normal Sinus Rhythm after Coronary Artery Bypass Graft.胺碘酮治疗的心房颤动患者与冠状动脉搭桥术后窦性心律正常患者住院时间的比较。

J Cardiovasc Thorac Res. 2012;4(1):17-20. doi: 10.5681/jcvtr.2012.004. Epub 2012 Feb 17.

Cell and gene therapy for arrhythmias: Repair of cardiac conduction damage.细胞和基因治疗心律失常：心脏传导损伤的修复。

J Geriatr Cardiol. 2011 Sep;8(3):147-58. doi: 10.3724/SP.J.1263.2011.00147.

QTc prolongation assessment in anticancer drug development: clinical and methodological issues.抗癌药物研发中的QTc间期延长评估：临床与方法学问题

Ecancermedicalscience. 2009;3:130. doi: 10.3332/ecancer.2009.130. Epub 2009 Jan 12.

The use of oral ranolazine to convert new or paroxysmal atrial fibrillation: a review of experience with implications for possible "pill in the pocket" approach to atrial fibrillation.口服雷诺嗪用于转复新发或阵发性心房颤动：对可能采用的心房颤动“口袋药”方法的经验回顾

Indian Pacing Electrophysiol J. 2009 Sep 1;9(5):260-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验